Market’s Reaction to Week’s Earnings - Key

George Brooks |

Investor’s first read – Daily edge before the open

DJIA: 17,366

S&P 500:  2,017                               

Nasdaq  Comp.: 4,638

Russell 2000:1,170

Tuesday, November  4, 2014     9:12 a.m.  DAILY BEFORE the OPEN



    If Q3 earnings reports from 80 S&P 500 companies this week don’t drive the stock market higher, there is reason to expect another sharp correction on the order of the 9%-plus one in September/October.

    I really believe the Street is in a quandary, unsure what to do about plunging oil prices and weakening economies abroad.

    October’s rally was triggered by better-than-expected Q3 earnings, but the stock market  has really only recouped what it lost a month ago.

    If this market can ignore the lingering uncertainties of softening economies abroad, deflation, Russia/Ukraine, ISIS and Ebola, it has a chance to go higher.

    Clearly, the fact the U.S. stock and bond market appear to be the safest place for monies seeking a refuge or a chance to earn a return is a positive.

    However, something seems amiss here, kind of phony. Maybe it’s the election, maybe something not yet factored in.


    BEST SIX MONTHS for OWNING STOCKS (Nov. 1 to May 1)*

   This six months period has consistently outperformed the six months between May 1 and November 1, though both have been interrupted by counter moves.

    It is important to consider the possibility that the six month period starting Monday will be an exception. This would not only go counter to the Best Six Months pattern, it would contradict the market’s bullish record for rising  in pre-presidential  election years.

    If the Washington scene has been ugly and dysfunctional over the last four years, it stands to get even more so regardless of who comes out ahead next Tuesday.   Just keep an open mind.  None of these seasonal tendencies is infallible.  These seasonal patterns, and others are presented in great detail in the Stock Trader’s Almanac – “must” reading.



By technically analyzing each of the 30 Dow industrials then using the Dow “divisor” to convert the data back into the DJIA, I can get a better read on what is primary support and a secondary support.

  As of the 10/8 close:  Resistance 17,532; Primary Support: 17,052; and Secondary Support: 16,930.

   NOTE: These calculations generally hold for longer periods of time, but need to be changed when the market is hit with excessive volatility.

   The resistance and support levels listed daily may differ, since they are shorter term.



     For detailed analysis of both the U.S. and Foreign economies along with charts, go Also included is an explanation of each indicator. If you want to know when the next Employment report or any other key report will be released that info is also there under “event release date.”


PMI Mfg Ix. (9:45): Oct. index down to 55.9 from 57.5 in Sept.

ISM Mfg. Ix (10:00): Oct. up to 59.0 from56.6 in Sept..

Construction Spend (10:00): Sept. down 0.4 pct. after  drop of 0.5 pct in Aug.

Global Mfg. Ix. (11:00): Sept. unchg. At 52.7


ICSC Goldman Store Sales (7:45:)

Factory Orders (10:00):


MBA Purchase Apps, Refi’s (7:00):

ADP Employment 8:15):

Fed’s Kockerlakota speaks (9:15):

Fed’s Lacker speaks (9:30):

PMI Services Ix.(9:45):

ISM Non-Mfg Ix (10:00):

Fed’s Rosengran speaks (10:00)


Jobless Claims (8:30):

Productiviy/Costs (8:30):


Employment Situation (8:30):

Consumer Credit (3:00):



Oct. 20   DJIA  16,380   Critical Week for Bulls

Oct. 21   DJIA  16,399   Market Attacking Key Resistance

Oct. 22   DJIA   16,614  Just a Rally of End of the  Correction ?

Oct. 23   DJIA   16,461  BIG Day for Economic Reports

Oct. 24   DJIA   16,677  DJIA – a Portfolio of Small Cap Stocks ?

Oct. 27  DJIA    16,805  Wednesday: Wall Street: Pass, or Fail

Oct. 28   DJIA   16,817  Bullard Bull !!

Oct. 29   DJIA   17,005  Fed Decision – Major Market Reaction ?

Oct. 30   DJIA   16,974  Interest Rate Angst Next

Oct. 31   DJIA   17,195  Raise Some Cash

*Stock Trader’s Almanac

George  Brooks

A Game-On Analysis,  LL

“Investor’s first read – a daily edge before the open”

Investor’s first read, is a Game-On Analysis,LLC publication for which George Brooks is sole owner, manager and writer. Neither Game-On Analysis, LLC, nor George  Brooks  is  registered as an investment advisor.  Ideas expressed herein are the opinions of the writer, are for informational purposes, and are not to serve as the sole basis for any investment decision. References to specific securities should not be construed  as particularized or as investment advice as recommendations that you or any investors purchase or sell these securities on their own account. Readers are expected to assume full responsibility for conducting their own research pursuant to investment decisions in keeping with their tolerance for risk.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Veritas Pharma Inc.

Veritas Pharma Inc, formerly Seashore Organic Medicine Inc is an emerging producer and distributor of medical marijuana.

Private Markets

Santo Diablo Mezcal

Santo Diablo Mezcal has been created to capitalize on a boom sector of the beverage market currently full of many small unmemorable products by producing one sexy, household, easily recognizable…


Pinterest is a visual discovery and planning tool. Users ("Pinners") use the site and apps to get ideas for their future, such as recipes, places to travel, and products to…